OpenAI acquires Orchestra Bio
OpenAI has acquired Orchestra Bio to integrate AI capabilities into life sciences research and development operations. The acquisition aims to help biopharma teams accelerate drug development processes.
Source: OpenAI
OpenAI has acquired Orchestra Bio to integrate AI capabilities into life sciences research and development operations. The acquisition aims to help biopharma teams accelerate drug development processes.
Source: OpenAI
PSET has developed an AI-first platform designed to automate admissions processing, reducing administrative burden and manual paperwork for staff. The platform uses intelligent automation to handle high volumes of admissions inquiries. Source: ITWeb
Palo Alto Networks is in acquisition discussions to purchase Clutch, an AI agent security startup, for approximately $500 million. The startup was previously valued at $85 million and is backed by venture firms Lightspeed and SignalFire. Source: TechCrunch
Cult.fit, a fitness platform, has adopted Codex to assist teams across different functions in building tools and improving operational efficiency. The implementation is intended to accelerate workflows and transform how the organization manages work processes. Source: OpenAI
Australian universities are integrating ChatGPT and AI tools into their curricula and expanding student access to these technologies as part of workforce preparation. The initiative aims to ensure graduates are equipped with AI literacy and skills for an AI-enabled work environment. Source: OpenAI